Jan. 14 at 4:52 PM
Wall Street sees airlines as an unexpected beneficiary of the weight-loss drug boom, as wider use of new GLP-1 pills could lower average passenger weight and reduce fuel costs, Jefferies said. Fuel is airlines’ largest expense, and even small weight reductions can meaningfully improve efficiency.
Jefferies estimates a 10% drop in average passenger weight could cut total aircraft weight by about 2%, lower fuel costs by up to 1.5%, and boost earnings per share by as much as 4%. With major U.S. carriers expected to spend nearly
$39 billion on fuel in 2026, the impact could be material.
The firm estimates a 2% decline in passenger weight alone could drive roughly 4% EPS upside across large carriers, with the biggest benefit for airlines most sensitive to fuel costs. The analysis highlights how even modest weight changes — long a focus for airlines — can translate into meaningful savings over thousands of flights.
$JEF $AAL $DAL $UAL $LUV